U.S., May 12 -- ClinicalTrials.gov registry received information related to the study (NCT07578363) titled 'An Investigation of FID 123472 Ophthalmic Solution to Vehicle for the Reduction of Ocular Redness in Adults' on May 05.
Brief Summary: The purpose of this study is to evaluate the efficacy and safety of an investigational ophthalmic solution in adults with ocular redness caused by minor eye irritations.
Study Start Date: Sept., 2026
Study Type: INTERVENTIONAL
Condition:
Ocular Hyperemia
Intervention:
DRUG: Apraclonidine Ophthalmic Solution, 0.125% Unit Dose Preservative Free
Investigational ophthalmic solution applied topically to the eye in a unit dose preservative free (UDPF) formulation
DRUG: Vehicle
Inactive ingredients ...